Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

12 Oct 2021 07:20

RNS Number : 7748O
Anpario PLC
12 October 2021
Β 

Anpario plc("Anpario" or the "Company")

Β 

Director/PDMR Shareholding

Β 

Anpario announces that, on 11 October 2021, it has allotted a total of 50,000 new Ordinary Shares. The Ordinary Shares have been issued at a subscription price of 620 pence per Ordinary Share, being the closing price of an Ordinary Share on 8 October 2021, pursuant to The Anpario plc Employees' JSOP (the "Plan").

Β 

The Ordinary Shares have been issued into the respective joint beneficial ownership of (i) Marc Wilson, Group Finance Director, and (ii) the trustee of the Trust upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director concerned, the Company and the Trustee. The subscription price has been paid by the Trust out of funds advanced to it by the Company.

Β 

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the jointly owned Ordinary Shares above the initial market value of 620 pence per share, less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost. Jointly owned Ordinary Shares will become vested if the participant remains with the Company for a minimum period of 3 years.

Β 

Effect of the transactions

Β 

The beneficial interests held before and after the above transactions and remaining unchanged are:

Β 

Director

Ordinary shares

SAYE options

Marc Wilson

9,676

5,577

Β 

The jointly owned Ordinary Shares held by the Directors of the Company before and after the above transactions will be:

Β 

Director

Interests in jointly owned Ordinary Shares prior to the transactions:

New interests in jointly owned Ordinary Shares issued under JSOP

Interests in jointly owned Ordinary Shares following the transactions

Marc Wilson

20,000

50,000

70,000

Β 

An application has been made to the London Stock Exchange plc for the admission to trading on AIM of 50,000 Ordinary Shares in respect of these shares awarded under the JSOP. It is expected that admission of these new Ordinary Shares will become effective on 15 October 2021 ("Admission"). These new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

Β 

Following Admission, the Company's total issued share capital is 23,678,196 Ordinary Shares. The Company holds 440,388 Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company is 23,237,808. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Β 

Share plan limits

On 16 September 2016, Anpario announced limits on future awards made under its share plans. That limit is the total number of new shares over which future awards may be made, when added to the total number of shares issued and issuable under awards granted on 16 September 2016 and any awards which are outstanding as at that date shall not exceed 16.3% of the total of the number of shares in issue from time to time.

Β 

The JSOP award mentioned above substantially utilises the remaining headroom under this share plan limit. Anpario considers it necessary to have in place a competitive senior executive employment package, including equity awards and to ensure that existing managers and directors are properly incentivised. As such, a review is currently being undertaken to determine potential future changes to share plan limits and awards, once this process has concluded then further details will be announced as appropriate.

Β 

Β 

Β 

Enquiries:

Anpario plc

Β 

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

Karen Prior, Corporate Responsibility Director & Company Secretary

+44(0) 1909 537380

Β 

Β 

Β 

Peel Hunt LLP (NOMAD)

+44 (0)20 7418 8900

Adrian Trimmings

Β 

Andrew Clark

Β 

Will Bell

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHMZMMGVZRGMZG
Date   Source Headline
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
13th Oct 200611:30 amRNSSuspension - Kiotech Int
29th Sep 20064:56 pmRNSInterim Results - Correction
27th Sep 20067:00 amRNSInterim Results
5th Sep 20062:46 pmRNSDirectorate Change
23rd Aug 20069:10 amRNSDiv currency conversion rate
22nd Aug 200610:28 amRNSDoc re. Interim Report
21st Aug 20069:11 amRNSDirector/PDMR Shareholding
18th Aug 20061:57 pmRNSDirector/PDMR Shareholding
10th Aug 200611:27 amRNSDirector/PDMR Shareholding
7th Aug 200610:20 amRNSDirector/PDMR Shareholding
31st Jul 20068:00 amRNSInterim Results
28th Jul 200611:00 amRNSDirectorate Change
12th Jul 200611:00 amRNSTrading Statement
3rd Jul 20067:00 amRNSChange of Adviser
19th Jun 20064:57 pmRNSNotice of AGM
7th Jun 20063:05 pmRNSDirector/PDMR Shareholding
6th Jun 20067:01 amRNSFinal Results
5th Jun 20064:23 pmRNSChange in registered office
16th May 20063:48 pmRNSDirectorate Change
16th May 20063:44 pmRNSDirectorate Change
10th May 20063:02 pmRNSDirector/PDMR Shareholding
10th May 20062:52 pmRNSChanges to Board
9th May 20061:11 pmRNSDirector/PDMR Shareholding
8th May 20062:55 pmRNSDividend Declaration
8th May 20062:50 pmRNSDirector/PDMR Shareholding
5th May 20064:09 pmRNSDirector/PDMR Shareholding
28th Apr 20062:23 pmRNSDirector/PDMR Shareholding
28th Apr 20062:01 pmRNSDirector/PDMR Shareholding
26th Apr 20064:00 pmRNSAnooraq-Anglo Plats Project
19th Apr 20062:00 pmRNSDirector/PDMR Shareholding
12th Apr 20063:09 pmRNSRhodium Contract Sales
12th Apr 20062:00 pmRNSStatement re. Anglo Platinum
29th Mar 200612:04 pmRNSResults of AGM
20th Mar 20062:00 pmRNSDirector/PDMR Shareholding
15th Mar 200610:00 amRNSCurrency conversion rate
23rd Feb 20069:00 amRNSDirectorate Change
13th Feb 20067:15 amRNSResults of Subsidiary
13th Feb 20067:01 amRNSKola licences agreed
13th Feb 20067:00 amRNSFinal Results
19th Jan 200612:04 pmRNSTrading Statement
10th Jan 200612:21 pmRNSBlocklisting Interim Review
10th Jan 200612:11 pmRNSBlocklisting Interim Review
6th Jan 200612:01 pmRNSAdditional Listing
20th Dec 20059:26 amRNSDirector/PDMR Shareholding
15th Dec 200510:00 amRNSPool agreement at Marikana
30th Nov 20054:30 pmRNSIssue of Options
24th Oct 20054:25 pmRNSDirector/PDMR Shareholding
30th Sep 20057:03 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.